Share
CNBC Pro

Vaccine distribution is still unknown, stick with barbell approach: Nancy Tengler

Pfizer vaccine news propels stocks to new highs. CNBC's Kelly Evans discusses the market action and the impact of an effective coronavirus vaccine with Steve Auth of Federated Hermes, Nancy Tengler of Laffer Tengler and Peter Boockvar of Bleakley Advisory Group. I think the fundamentals are really good, says Tengler. And the news today just sort of opened the floodgates to allow investors to see that, she adds.
06:00
Mon, Nov 9 20201:56 PM EST

watch now
VIDEO02:48
CNBC ProThese tech stocks remain 'incredible companies' to buy when there's a dip: Kleinwort Hambros CIO
watch now
VIDEO01:53
CNBC ProThis China consumer stock has the ability to mitigate cost pressure: Portfolio manager
watch now
VIDEO03:08
CNBC ProTigress Financial Partners revised target price for Airbnb
watch now
VIDEO03:00
CNBC Pro'Chips have to be in a portfolio', strategist names her top chip stocks
watch now
VIDEO45:14
CNBC ProMad Money with Jim Cramer — June 17, 2021